Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.22.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities      
Net income (loss) $ (1,565) $ 501 $ 1,232
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation and amortization expense 1,011 932 794
Share-based compensation expense 140 110 131
Non-cash interest expense 19 51 143
Amortization of debt issuance costs, premium and discount 72 114 103
Reduction of right-of-use assets 393 291 350
Loss on modification or extinguishment of debt 116 217 55
Total losses (gains) on derivatives, net 5,989 211 (400)
Net cash provided by (used for) settlement of derivative instruments (1,579) 74 138
Impairment expense and loss on disposal of assets 5 6 23
Impairment expense and loss on equity method investments 24 126 88
Deferred taxes (715) 40 (521)
Repayment of paid-in-kind interest related to repurchase of convertible notes (190) (911) 0
Other 4 2 0
Changes in operating assets and liabilities:      
Accounts and other receivables, net of current expected credit losses (799) (154) 1
Inventory (409) 21 11
Margin deposits (741) (13) 6
Other current assets (101) (14) (24)
Accounts payable and accrued liabilities 1,144 54 52
Deferred revenue 55 (23) 22
Operating lease liabilities (418) (277) (366)
Other, net 14 (93) (5)
Net cash provided by operating activities 2,469 1,265 1,833
Cash flows from investing activities      
Property, plant and equipment (966) (1,839) (3,056)
Proceeds from sale of fixed assets 68 0 0
Investment in equity method investment 0 (100) (105)
Other (14) (8) (2)
Net cash used in investing activities (912) (1,947) (3,163)
Cash flows from financing activities      
Proceeds from issuances of debt 5,911 7,823 6,434
Redemptions and repayments of debt (6,810) (6,940) (4,346)
Debt issuance and other financing costs (53) (125) (51)
Debt modification or extinguishment costs (82) (172) (15)
Distributions to non-controlling interest (649) (626) (590)
Payments related to tax withholdings for share-based compensation (48) (43) (19)
Repurchase of common stock (9) (155) (249)
Cash dividends to shareholders (85) 0 0
Other 8 3 4
Net cash provided by (used in) financing activities (1,817) (235) 1,168
Net decrease in cash, cash equivalents and restricted cash and cash equivalents (260) (917) (162)
Cash, cash equivalents and restricted cash and cash equivalents—beginning of period 2,077 2,994 3,156
Cash, cash equivalents and restricted cash and cash equivalents—end of period $ 1,817 $ 2,077 $ 2,994